Advanced Search
  • May 21, 2013
    Q4 Revenue of $4.5 Billion Grew 5% at Constant Currency; 4% as Reported

    MINNEAPOLIS - May 21, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2013, which ended April 26, 2013. The Company reported worldwide...

  • May 21, 2013
    Proven Lead Expands Access to MRI for Patients with Slow Heartbeat

    TOLOCHENAZ - May 21, 2013 -- Medtronic today announced CE Mark (Conformité Européenne) and launch of its CapSureFix Novus(TM)5076 Lead, which is now approved in the EU for use in an MRI...

  • May 21, 2013
    Three Analyses Presented at EuroPCR Demonstrate Device's Durability in Addressing Common Clinical Challenge

    PARIS -- May 22, 2013 -- Addressing one of the most common clinical challenges in the treatment of complex coronary artery disease, three separate analyses on the program for EuroPCR this week...

  • May 20, 2013
    Backed by Robust Clinical Data on Broad Product Family, New Thrombus Removal System Offers Superior Deliverability

    MINNEAPOLIS -- May 20, 2013 -- Expanding its portfolio of medical technology for the interventional treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT) announced today that the Export...

  • May 20, 2013
    Live On. Give On: Ten inspirational people will be awarded a $20,000 charitable donation and be honored at an awards celebration in Hawaii as part of the first annual Bakken Invitation

    MINNEAPOLIS - May 20, 2013- Medtronic, Inc. (NYSE: MDT) announced today that applications are being accepted for the inaugural Bakken Invitation, a global program designed to celebrate those who,...